Timeline

Corinne Jallet

Technician

17 Feb 2023

publication

Hemisynthetic alkaloids derived from trilobine are antimalarials with sustained activity in multidrug-resistant Plasmodium falciparum.

01 Jun 2022

publication

Identification of Chemical Probes Targeting MBD2.

01 Apr 2022

publication

Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studies.

05 Jan 2021

publication

Broad spectrum compounds targeting early stages of RABV infection

09 Jan 2018

team

Epigenetic Chemical Biology

23 Oct 2013

publication

A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release

04 Dec 2010

publication

Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheep

12 Aug 2009

publication

Peptides that mimic the amino-terminal end of the rabies virus phosphoprotein have antiviral activity

01 Jan 2008

publication

Canine adenovirus based rabies vaccines

01 Jan 2006

publication

Rabies: epidemiological tendencies and control tools

26 Sep 2005

publication

A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture

01 Jul 2004

publication

Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides

01 Mar 2003

publication

Inactivated rabies vaccine control and release: use of an ELISA method

01 Dec 2001

publication

Interaction of lyssaviruses with the low-affinity nerve-growth factor receptor p75NTR

14 Oct 1999

publication

Immunization of dogs with a DNA vaccine induces protection against rabies virus

17 Mar 1999

publication

Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine?

01 Jan 1999

publication

Chimeric lyssavirus glycoproteins with increased immunological potential

01 Sep 1996

publication

A little guide for advanced search:

Timeline

Hemisynthetic alkaloids derived from trilobine are antimalarials with sustained activity in multidrug-resistant Plasmodium falciparum.

Identification of Chemical Probes Targeting MBD2.

Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studies.

Broad spectrum compounds targeting early stages of RABV infection

Epigenetic Chemical Biology

A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release

Canine adenoviruses elicit both humoral and cell-mediated immune responses against rabies following immunisation of sheep

Peptides that mimic the amino-terminal end of the rabies virus phosphoprotein have antiviral activity

Canine adenovirus based rabies vaccines

Rabies: epidemiological tendencies and control tools

A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture

Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides

Inactivated rabies vaccine control and release: use of an ELISA method

Interaction of lyssaviruses with the low-affinity nerve-growth factor receptor p75NTR

Immunization of dogs with a DNA vaccine induces protection against rabies virus

Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine?

Chimeric lyssavirus glycoproteins with increased immunological potential

The antigen-specific cell-mediated immune response in mice is suppressed by infection with pathogenic lyssaviruses